Early-stage Capital Solutions for Advanced Therapy Tools & Technology Start-ups
A disruptive acceleration capital solutions provider for early-stage founders, Altius Bioventures aims to bridge gaps in tools and technologies, enabling affordable, accessible advanced therapy treatments globally. We support innovative startups from pre-seed to Series A.
We invest in technologies that can reduce costs, save time and increase global accessibility of Advanced Therapies
Our Investment Thesis
Unique and Global
Our experienced team and advisors have extensive relationships with both potential portfolio companies and purchasers for exits in the Advanced Therapy space, providing global coverage and invaluable expertise in key Advanced Therapy developments worldwide.
Investment Focus
We focus on Advanced Therapy related tools and enabling technologies, including critical reagents, assays, and diagnostics. Additionally, we invest in systems for the manufacturing and logistics supply chain, analytical technologies, and data capture (raw material, in-process, and final release). Machine learning and artificial intelligence are also key areas of our investment focus.
Sector Focus
We prioritize early-stage companies driving innovation in Advanced Therapy technologies, aiming to reduce costs, save time, and enhance accessibility. Our tech-focused strategy capitalizes on our global team's unique strengths and extensive industry experience, granting us a competitive edge in a less saturated market.
Investment Metrics
We are structured as an operating corporation with SPVs which take an active business interest in all our investments, ensuring hands-on engagement and value creation. We require a minimum investment of US$250,000, and our objective is to build a diversified portfolio of SPVs across categories of tools and technologies in CGT.
Entrepreneurial Growth Partner
ABV commits its full resources to every investment, from pre-seed to Series A, building trust and aligning values with AT tools and technologies companies long before a collaboration begins. Our ongoing engagement enhances the potential for higher-value exits.
Disciplined Analysis
Our approach emphasizes rigorous methods, validation, and thorough data analysis for evaluating potential investments and managing portfolios. We use a structured process to validate opportunities, employing a robust risk mitigation model.
Active Value Creation
ABV offers a unique team of experienced entrepreneurs, investors, and advisors, to drive growth and maximizes value for portfolio companies. Each portfolio SPV has an ABV partner assigned, and our global team of advisors enables teams of entrepreneurs to build and scale.
Diversity, Equality and Inclusion
We emphasize and integrate diversity, equality, and inclusion as core principles within our investment portfolio. Our commitment extends beyond financial metrics, reflecting a conscious effort to support businesses that reflect a rich mosaic of backgrounds and experiences.